Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

National Bank Of Canada Q2 Net Profit Declines

National Bank of Canada (NA.TO: Quote), Friday reported net income of C$434 million or C$2.49 per share for the second quarter, compared with C$553 million or C$3.22 per share last year. Last year's profit included a C$198 million net gain realized on the Natcan transaction.

Excluding specified items, the company reported net income of C$369 million or C$2.08 per share, compared with C$347 million or C$1.95 per share during the same quarter last year.

Revenue for the three-month period was C$1.38 billion, a decrease from prior year's C$1.49 billion. Adjusted revenues for the quarter were C$1.25 billion compared with C$1.22 billion during the corresponding quarter last year.

The company further announced an increase in dividend on its common shares from C$0.83 to C$0.87 for the quarter ending July 31. This dividend will be payable on August 1 to shareholders of record on June 20.

In a separate statement, the firm announced that its board has authorized a normal course issuer bid to purchase for cancellation of up to 2 percent of its issued and outstanding common shares, representing approximately 3,246,676 common shares. The company said that the normal course issuer bid will begin on or about June 20 and will end at the latest on or about June 19.

Register
To receive FREE breaking news email alerts for National Bank of Canada and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.